Sanofiís Dengue Vaccine Meets Goal in Clinical Trial

by Kathy Jones on  November 4, 2014 at 8:49 PM Corporate News
RSS Email Print This Page Comment bookmark
Font : A-A+

French pharmaceutical giant Sanofi revealed that its experimental dengue vaccine has managed to meet its primary goal during a late stage clinical trial and was found to be highly effective even against the most severe type of the disease.
 Sanofiís Dengue Vaccine Meets Goal in Clinical Trial
Sanofiís Dengue Vaccine Meets Goal in Clinical Trial

The trial was conducted in Brazil and Latin America and the researchers revealed that it was 95.5 percent effective in treating severe cases of dengue, including the hemorrhagic type.

More than 31,000 people from 10 endemic countries from Asia and Latin America took part in the study and the company revealed that the vaccine, claimed to be the world's first against dengue fever, will be made available by the second half of 2015 subject to regulatory approval.


Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Dengue Fever Dengue / Dengue Hemorrhagic Fever Mosquito Diseases Clinical Trials Dengue and Homeopathy Chikungunya and Homeopathy Clinical Trials - The Past and The Future Clinical Trials - Different Phases of the trial Chikungunya Dengue 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive